Additionally, we investigated cancer cell–fibroblast crosstalk, focusing on the expression of activin receptor type I (ACVR1) in fibroblasts and bone morphogenetic protein 7 (BMP7) in cancer cells as potential therapeutic targets. This evidence concerns the gene ACVR1 and cancer.